Navigation Links
AACR, NCI and EORTC to host molecular targets and cancer therapeutics conference
Date:10/15/2009

What: The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics is the location to hear about late-breaking data on emerging cancer therapies. This year's conference brings together delegates from all over the world to discuss innovation in drug development, target selection and the impact of new discoveries in molecular and cell biology.

To help you plan your coverage of the conference, the program schedule is available online at www.aacr.org. Although the full abstracts will not be available until the conference, an electronic press kit containing the press releases and select highlighted abstracts will be available to subscribing reporters on Nov. 9, 2009, via Eurekalert and Newswise, and by request to the AACR Communications and Public Relations Department.

More than 1,000 abstracts will be presented for the first time at the conference, complementing an outstanding program of scientific and educational events. The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics attracts world leaders in cancer research and treatment, including clinical oncologists, industry leaders, basic scientists and translational researchers who are working to improve patient care with the ultimate goal of eradicating cancer.

When: Nov. 15-19, 2009

Where: Hynes Convention Center, Boston


'/>"/>

Contact: Natalie Poole
natalie.poole@aacr.org
267-646-0619
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. AACR, BCRF award inaugural grants in translational breast cancer research
2. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
3. New molecular regulators of hyperthyroidism and goiter
4. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing
5. UC health news: molecular pathway may predict chemotherapy effectiveness
6. New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed
7. Story ideas from Molecular & Cellular Proteomics
8. Lets talk -- new paradigms in the research of the biomolecular composition of water
9. Scientists unveil structure of molecular target of many drugs
10. Potential new therapeutic molecular target to fight cancer
11. NIH selects LIAI for major study on allergy molecular causes and possible treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
Breaking Biology Technology: